Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

Stopped early

Conditions studied: Diabetes Mellitus

In brief

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

Key facts

Study ID

NCT02040025

Run by

David Grant U.S. Air Force Medical Center

People needed

2

Starts

2014-04-01

Expected to finish

2016-10-01

Last updated by the study team

2020-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age equal to or greater than 18
• Diagnosis of Type 1 or Type 2 diabetes mellitus
• Prescribed EECP therapy in the DGMC EECP clinic
• Medically cleared for EECP therapy
• TRICARE beneficiary

You may not qualify if…

• DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus

Where it is running

• David Grant USAF Medical Center — Travis Air Force Base, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.